Press release
Knee Osteoarthritis Marketed and Emerging Pipeline Drugs Assessment | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies
Knee Osteoarthritis Pipeline
"Knee Osteoarthritis Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Knee Osteoarthritis Therapeutics Market.
The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).
The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Knee Osteoarthritis Pipeline Analysis
The report provides insights into:
- The report provides detailed insights into the key companies that are developing therapies in the Knee Osteoarthritis Market.
- The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Knee Osteoarthritis treatment.
- It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
- It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
- Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Knee Osteoarthritis market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Learn More about the Clinical and Commercial Development Activities in the Knee Osteoarthritis Therapeutics Domain:
https://www.delveinsight.com/report-store/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Route of Administration
Knee osteoarthritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
- Oral
- Parenteral
- Intravenous
- Subcutaneous
- Topical
Molecule Type
Products have been categorized under various Molecule types, such as
- Monoclonal Antibody
- Peptides
- Polymer
- Small molecule
- Gene therapy
Request for Sample PDF to Understand More About the Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/report-store/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Knee Osteoarthritis Therapeutics Analysis
There are approx. 40+ key companies developing therapies for Knee osteoarthritis. Currently, Bone Therapeutics is leading the therapeutics market with its Knee osteoarthritis drug candidates in the most advanced stage of clinical development.
The Leading Companies in the Knee Osteoarthritis Therapeutics Market Include:
Bone Therapeutics, Moebius Medical, UnicoCell Biomed CO. LTD, Gwo Xi Stem Cell Applied Technology, Bioventus LLC, CAR-T (Shanghai) Biotechnology, Novartis, Personalized Stem Cells, Centrexion Therapeutics, Akan Biosciences, Samumed LLC, Purdue Pharma, Anika Therapeutics, Peptinov SAS, Flexion Therapeutics, Centrexion Therapeutics, Taiwan Liposome Company, Techfields Pharma, AstraZeneca, Ampio Pharmaceuticals, BioIntegrate, Sorrento Therapeutics, Swiss Medica XXI Century S.A., OrthoTrophix, R-Bio, Amzell, Eupraxia Pharmaceuticals, Meluha Life Sciences SDN BHD, Vivex Biomedical, Orient Europharma Co., Ltd., Paradigm Biopharmaceuticals, Abbvie, Galapagos NV, Regeneron Pharmaceuticals, Xalud Therapeutics, Yooyoung Pharmaceutical, Eupraxia Pharmaceuticals, Celltex Therapeutics Corporation, Eli Lilly and Company, Sclnow Biotechnology, Mestex AG, Mitsubishi Tanabe Pharma Corporation, Propella Therapeutics, PT. Prodia Stem Cell Indonesia, and others.
Knee osteoarthritis Emerging and Marketed Drugs Covered in the Report Include:
- JTA-004: Bone Therapeutics
- MM-II: Moebius Medical
And many more
Get an in-depth Assessment of the Emerging Therapies and Key Companies:
https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Knee Osteoarthritis Current Treatment Patterns
4. Knee Osteoarthritis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Knee Osteoarthritis Late-Stage Products (Phase-III)
7. Knee Osteoarthritis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Knee Osteoarthritis Discontinued Products
13. Knee Osteoarthritis Product Profiles
14. Knee Osteoarthritis Key Companies
15. Knee Osteoarthritis Key Products
16. Dormant and Discontinued Products
17. Knee Osteoarthritis Unmet Needs
18. Knee Osteoarthritis Future Perspectives
19. Knee Osteoarthritis Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Knee Osteoarthritis Marketed and Emerging Pipeline Drugs Assessment | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies here
News-ID: 2959069 • Views: …
More Releases from DelveInsight Business Research
Gastric Cancer Market to Exceed USD 700 Million in HER2+ Segment by 2034 Across …
Gastric cancer is the fifth most common malignancy worldwide, with incidence varying by region and highest rates reported in Eastern Asia and Eastern Europe. Japan records the highest burden among the 7MM, with about 129,500 cases in 2024. Many patients, particularly in Western countries, are diagnosed at advanced (Stage IV) stages, while Japan detects more cases early (Stage I). In the US, around 35% present with metastatic disease at diagnosis,…
Myelofibrosis Market to Double by 2034, Surpassing USD 5.6 Billion Across 7MM wi …
The Myelofibrosis market across the seven major markets (7MM) is anticipated to experience significant growth, rising from approximately USD 2,602 million in 2025 to nearly USD 5,638 million by 2034, reflecting a compound annual growth rate (CAGR) of about 9% during the forecast period.
In 2024, the market was valued at around USD 2.2 billion, with the United States leading at nearly USD 1.7 billion, far surpassing the EU4, the United…
Triple-Negative Breast Cancer Clinical Trial Landscape Expands With 170+ Pipelin …
An expanding portfolio of novel therapies for triple-negative breast cancer (TNBC) including TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics), VIP236 (Vincerx Pharma), and CFI-400945 (Treadwell Therapeutics) is anticipated to significantly influence market expansion and transform the TNBC treatment landscape.
DelveInsight's Triple Negative Breast Cancer Pipeline Insight report offers an extensive evaluation of more than 165 companies and over 170 therapeutic candidates advancing through the TNBC pipeline. The…
Asthma Market to Witness Steady Growth Through 2034 Driven by Novel Biologics an …
DelveInsight's latest Asthma Market Insights, Epidemiology, and Market Forecast - 2034 report provides an in-depth evaluation of current treatment practices, emerging asthma drugs, market share of individual therapies, and forecasted market trends across the seven major markets (7MM) - the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
The asthma market is expected to experience sustained growth over the next decade, supported by the launch of…
More Releases for Knee
Vita Knee Relieve Review: Safe & Effective Knee Pain Solution or Hype?
Real User Results, Pros & Cons, Price, and Where to Buy?
Vita Knee Relieve is a modern knee support device designed to help reduce knee pain, improve comfort, and support joint mobility. Unlike traditional braces that simply compress the knee or temporary pain relievers that mask symptoms, this device combines support and therapeutic comfort to provide soothing relief where it's needed most.
Ergonomically designed and easy to wear, Vita Knee Relieve helps…
Vita Knee Relieve Reviews: Can This At-Home Knee Therapy Device Really Help With …
TL;DR Summary:
Vita Knee Relieve is a wearable knee therapy device that combines heat, vibration massage, and compression to help relieve daily knee discomfort. It is lightweight, cordless, and easy to use at home for just 15 minutes a day. Users report less stiffness, reduced swelling, and improved mobility. While it is not a medical cure, it is a convenient, drug-free option for anyone looking to support their knees and feel…
Knee Pain Relief Codes: The Ultimate Guide to Overcoming Knee Pain Naturally
The Knee Pain Relief Codes is a comprehensive online program designed to help individuals prevent and alleviate knee pain through proactive and natural methods. It provides valuable information on maintaining knee health, strengthening knee joints, and managing pain effectively. The program focuses on relieving joint discomfort, stiffness, and knee osteoarthritis using simple yet powerful exercises and techniques.
While knee pain is common, some conditions like knee osteoarthritis and joint injuries can…
Nooro Knee Massager Reviews 2024: How Does Nooro Knee Massager Work? Important U …
Nooro Knee Massager Reviews 2024: How Does Nooro Knee Massager Work? Important Update About Nooro Knee Massager, Buyers Beware!!!
Introducing the groundbreaking Nooro Knee Massager - a cutting-edge solution meticulously designed by leading knee pain experts. Experience unparalleled relief precisely when you need it, as this revolutionary device combines Red Light Therapy, Heat Therapy, and Massage Therapy for a holistic approach to knee discomfort. Not only is it remarkably cost-effective, but…
NOORO KNEE MASSAGER REVIEW 2023: BUYERS BEWARE! IS NOORO KNEE MASSAGER LEGIT?
In a world where knee discomfort has become increasingly prevalent, seeking effective solutions for pain relief has never been more important. Middle-aged and older individuals, in particular, often find themselves grappling with knee pain, hindering their daily activities and overall quality of life. This is where the Nooro Knee Massager steps in as a beacon of hope, offering targeted relief and relaxation for weary and sore knees. In this comprehensive…
Knee Sleeve Review 2022: (Must Read!) Is Knee Sleeve Working or Fake?
As people become older, the lubrication that surrounds their knee caps wears off, making them more susceptible to injury.
The pain may eventually become intolerable with long-distance walking, frequent use of the knee, particularly on rough surfaces, and other daily activities.
When this happens, a person can discover that they are unable to continue with their regular routines.
To solve this problem, get our Knee Sleeves and use them in…
